You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: March 2024 to February 2026

AbstractFullPdf
Mar 2024771784340
Apr 2024265266124
May 202423924076
Jun 202428829375
Jul 202434734769
Aug 202413313256
Sep 2024777838
Oct 202410110148
Nov 202420420660
Dec 202417417870
Jan 202513513646
Feb 202521121157
Mar 202514014077
Apr 202518618663
May 202514414556
Jun 2025979739
Jul 2025110
Sep 2025660
Feb 2026110
Total352035481294